Consider Smaller Biotech ETFs as Big Pharma Goes Shopping in 2021
December 31, 2020 at 08:00 AM EST
After a lull in mergers and acquisitions activity, Big Pharma could begin to use its cash stores to buy out smaller targets, potentially fueling the momentum in biotechnology-related exchange traded funds that target the small and mid cap segments. According to Dealogic data, total deal volume for...